SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2ctm'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_A_1LDA501_0
(CYTOSINE DEAMINASE)
2ctm VIGILIN
(Homo
sapiens)
5 / 12 HIS A  28
PHE A  52
ILE A  50
GLU A  83
LEU A  80
None
1.42A 4r88A-2ctmA:
undetectable
4r88A-2ctmA:
14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_B_1LDB501_0
(CYTOSINE DEAMINASE)
2ctm VIGILIN
(Homo
sapiens)
5 / 12 HIS A  28
PHE A  52
ILE A  50
GLU A  83
LEU A  80
None
1.44A 4r88B-2ctmA:
undetectable
4r88B-2ctmA:
14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_C_1LDC501_0
(CYTOSINE DEAMINASE)
2ctm VIGILIN
(Homo
sapiens)
5 / 12 HIS A  28
PHE A  52
ILE A  50
GLU A  83
LEU A  80
None
1.43A 4r88C-2ctmA:
undetectable
4r88C-2ctmA:
14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_D_1LDD501_0
(CYTOSINE DEAMINASE)
2ctm VIGILIN
(Homo
sapiens)
5 / 12 HIS A  28
PHE A  52
ILE A  50
GLU A  83
LEU A  80
None
1.42A 4r88D-2ctmA:
undetectable
4r88D-2ctmA:
14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_E_1LDE501_0
(CYTOSINE DEAMINASE)
2ctm VIGILIN
(Homo
sapiens)
5 / 12 HIS A  28
PHE A  52
ILE A  50
GLU A  83
LEU A  80
None
1.43A 4r88E-2ctmA:
undetectable
4r88E-2ctmA:
14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4R88_F_1LDF502_0
(CYTOSINE DEAMINASE)
2ctm VIGILIN
(Homo
sapiens)
5 / 12 HIS A  28
PHE A  52
ILE A  50
GLU A  83
LEU A  80
None
1.42A 4r88F-2ctmA:
undetectable
4r88F-2ctmA:
14.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RP8_C_ASCC501_0
(ASCORBATE-SPECIFIC
PERMEASE IIC
COMPONENT ULAA)
2ctm VIGILIN
(Homo
sapiens)
5 / 12 LEU A  82
HIS A  78
ILE A  31
ALA A  38
ILE A  50
None
0.99A 4rp8C-2ctmA:
undetectable
4rp8C-2ctmA:
9.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5NUK_A_Z80A201_1
(BETA-LACTOGLOBULIN)
2ctm VIGILIN
(Homo
sapiens)
5 / 10 ALA A  29
LYS A  41
ILE A  42
ILE A  79
VAL A  63
None
1.21A 5nukA-2ctmA:
undetectable
5nukA-2ctmA:
19.57